Skip to main content
. 2022 Oct 7;16(11):756–767. doi: 10.1111/crj.13549

TABLE 2.

Clinical characteristics of children in the MRMP* and MSMP* groups (n = 357)

Characteristics MRMP* n = 285 (100) MSMP* n = 72 (100) Total n = 357 (100) P a
BMI 18.14 ± 4.24 17.35 ± 3.04 17.98 ± 4.04 0.374
Respiratory admission history, n (%) 44 (15.4) 20 (27.8) 64 (17.9) 0.035
Hospital admission duration (day) 7.23 ± 4.30 6.36 ± 2.67 7.06 ± 4.04 0.374
Incident season 0.376
Spring (Mar, Apr, May) 29 (10.2) 5 (6.9) 34 (9.5)
Summer (Jun, Jul, Aug) 3 (1.1) 2 (2.8) 5 (1.4)
Autumn (Sep, Oct, Nov) 127 (44.6) 38 (52.8) 165 (46.2)
Winter (Dec, Jan, Feb) 126 (44.2) 27 (37.5) 153 (42.9)
Febrile days after initiation of antibiotic medication (day) 2.44 ± 2.23 1.58 ± 1.84 2.27 ± 2.18 0.007
Hypoxia (SpO 2  < 93%) 15 (5.3) 2 (2.8) 17 (4.8) 0.376
Pleural effusion, n (%) 36 (12.6) 2 (2.8) 38 (10.6) 0.035

Note: Values are presented as numbers (%) and mean ± standard deviation. Numbers in bold indicate significant differences (P < 0.05). Scale variables were analyzed using the chi‐squared test or Fisher exact test, and continuous variables were analyzed using Student's t‐test or Mann–Whitney U‐test.

Abbreviations: MRMP, macrolide‐resistant Mycoplasma pneumoniae; MRMP*, macrolide‐resistant M. pneumoniae with admission; MSMP, macrolide‐susceptible M. pneumoniae; MSMP*, macrolide‐susceptible M. pneumoniae with admission.

a

P was analyzed using a false discovery rate for multiplicity.